Neurocrine Biosciences shares owned by Bridgewater Associates
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Bridgewater Associates
from 13F filings
Historical chart of Bridgewater Associates investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Bridgewater Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $16M | 135k | 115.22 |
| 2024-06-30 | $12M | 88k | 137.67 |
| 2024-03-31 | $3.2M | 23k | 137.92 |
| 2023-12-31 | $3.1M | 24k | 131.76 |
| 2023-09-30 | $6.2M | 55k | 112.50 |
| 2023-06-30 | $5.2M | 55k | 94.30 |
| 2023-03-31 | $6.0M | 59k | 101.22 |
| 2022-06-30 | $634k | 6.5k | 97.49 |
| 2022-03-31 | $471k | 5.0k | 93.82 |
| 2021-12-31 | $215k | 2.5k | 85.08 |
| 2021-09-30 | $307k | 3.2k | 96.03 |
| 2021-06-30 | $577k | 5.9k | 97.24 |